FDA Moves to Curb Misuse of ADHD Meds FDA Moves to Curb Misuse of ADHD Meds

The FDA has announced updates to ADHD stimulant medication labels to note the serious risks of misuse, abuse, addiction, and the sharing of these drugs.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Psychiatry News Source Type: news